BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
ID: CBRND-BAA-22-01Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)

Original Source

https://sam.gov/opp/f2d01f5a6c444e32af543e9519a0805f/view
Timeline
    Description

    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.

    Point(s) of Contact
    Richard Totten
    (301) 619-2446
    richard.w.totten2.civ@army.mil
    Files
    Title
    Posted
    W911SR-22-R-CBRND BAA 11 Jun 22.pdf
    The Army Contracting Command at Aberdeen Proving Ground has issued a Broad Agency Announcement (BAA) for research and development efforts supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). Proposals are solicited from eligible organizations, including educational institutions and private industry, focusing on advanced medical countermeasures and enabling technologies for CBRN threats, with awards potentially involving procurement contracts, grants, or other transaction agreements. The announcement provides comprehensive guidelines for proposal submission, evaluation criteria, and administrative details for applicants.
    Similar Opportunities
    JPEO-CBRND CWMD BOTAA-24-01
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), is soliciting proposals through a Broad Agency Announcement (BAA) for innovative solutions in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. The BAA invites participation from a wide range of eligible sources, including educational institutions, nonprofit organizations, and private industry, to develop technologies such as sensor systems, aerosol technologies, and decontamination methods. This initiative is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' effectiveness on the battlefield and in homeland defense. Interested parties can submit preproposals at any time, with contact points for inquiries being Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil and Lionel Love at lionel.d.love.civ@army.mil.
    Request For Information - Administrative, Scientific, and Technical Support Services of the Chemical, Biological Radiological, & Nuclear Defense Research Coordinating Office
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking information from vendors regarding Administrative, Scientific, and Technical Support Services for the Chemical, Biological, Radiological, and Nuclear Defense Research Coordinating Office (CBRN DCO). The primary objectives include management and administration support, meeting and conference facilitation, research and analysis assistance, and financial support services, all of which require personnel to hold active SECRET clearances. This opportunity is crucial for enhancing defense capabilities through coordinated medical research and management expertise, with a contract period of one base year and up to four option years anticipated. Interested vendors must submit a Capability Statement by February 4, 2025, to Ms. Elizabeth O'Hara at elizabeth.m.ohara3.civ@health.mil, as this RFI does not imply a commitment to procure services nor will costs incurred in response be reimbursable.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    ACC-APG Natick Division FY25 Upcoming Aquisitions
    Dept Of Defense
    The Department of Defense, through the ACC-APG Natick Division, is announcing upcoming acquisitions for Fiscal Year 2025, aimed at enhancing capabilities related to chemical, biological, radiological, and nuclear defense. The procurement includes a variety of requirements such as the purchase of a CISCO AMP firepower system, professional services, peptide synthesizers, and HVAC maintenance, with contract values ranging from $110,032 to $49,201,610. These acquisitions are crucial for supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO CBRND) in its mission to ensure national security. Interested contractors can reach out to the Natick Division at usarmy.natick.acc-micc.mbx.ncd-internal-tasker@army.mil for further details, as the tentative award dates are set for early 2025.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    DHS BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT (R&D) COUNTERING WEAPONS OF MASS DESTRUCTION (CWMD)
    Homeland Security, Department Of
    Solicitation: Department of Homeland Security (DHS) is seeking Research and Development (R&D) proposals for countering Weapons of Mass Destruction (CWMD). The objective is to identify, explore, and demonstrate new technologies and capabilities to prevent, protect against, respond to, and mitigate nuclear, chemical, radiological, and biological threats and incidents. This 5-year Broad Agency Announcement (BAA) will provide an acquisition tool for innovative solutions. Proposals will be accepted within specified timeframes for various Areas of Interest (AOI) outlined in the notice. Interested parties can find more information on SAM.gov.
    DLA Emergent IV Research and Development Program
    Dept Of Defense
    The Department of Defense, specifically the Defense Logistics Agency, has issued a Combined Synopsis/Solicitation notice for the DLA Emergent IV Research and Development Program. This program aims to acquire research and development services in various areas of interest not covered by DLA's annual R&D program planning. The notice states that interested parties can submit a "White Paper" describing a specific project related to an Area of Interest listed in the attachment. If the White Paper is of interest, DLA may request technical and cost proposals for the project. The notice also mentions that the BAA attachment may be amended as needed to add, modify, or delete Areas of Interest. The ceiling for this BAA is $50 Million, and it will remain open for five years. For more information, interested parties should refer to the BAA attachment.
    Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generally Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves a partnership among U.S. interagency, academic, and industry stakeholders to leverage advanced simulation and machine learning technologies for the rapid design and optimization of biological products and small molecule drugs. The GUIDE program is critical for enhancing the preparedness and response capabilities against diverse threats, and interested parties must demonstrate technical relevance by contacting the primary point of contact, Joseph McCaffery, at joseph.w.mccaffery2.civ@army.mil. Participation is governed by a Participant Basic Agreement (PBA), and entities must be registered in the System for Award Management (SAM) prior to any award.